FASS logotyp
Receptbelagd

Peka på symbolerna och beteckningarna till vänster för en förklaring.

Kontakt

Sök apotek med läkemedlet i lager

Sök lagerstatus

Innohep®

LEO Pharma

Injektionsvätska, lösning i förfylld spruta 10000 anti-Xa IE
(Färglös/svagt gulaktig lösning)

Antikoagulantia

Aktiv substans:
ATC-kod: B01AB10
Utbytbarhet: Ej utbytbar
Läkemedel från LEO Pharma omfattas av Läkemedelsförsäkringen.
  • Vad är miljöinformation?

Miljöinformation

Miljöpåverkan

Tinzaparin

Miljörisk: Användning av kolhydrater bedöms inte medföra någon miljöpåverkan.


Läs mer

Detaljerad miljöinformation

The active ingredient in Tinzaparin LEO® is tinzaparin sodium. Tinzaparin sodium is a polysulphated and acetylated glucosaminoglycane sodium salt (carbohydrate) – see Enclosure 1.


According to the European Medicines Agency guideline on environmental risk assessments for pharmaceuticals, vitamins, electrolytes, amino acids, peptides, proteins, carbohydrates, lipids, vaccines and herbal medicinal products are exempted because they are unlikely to result in significant risk to the environment (EMA, 2006).


Therefore, no environmental information is required.


Enclosure 1 Physical and Chemical characteristics


Names

International Nonproprietary name (INN): Tinzaparin sodium


Chemical description: The majority of the components have a 2-O-sulpho-4-enepyranosuronic acid structure at the non-reducing end and a 2-N,6-O-disulpho-D glucosamine structure at the reducing end of their chain.


Chemical Abstracts Service (CAS) Number: 9041-08-1.




Description:

Physical form: Tinzaparin sodium is a white to almost white, amourphous powder, moderately hegroscopic substance. (Herr and Agerholm, 2011).




Structural formula:

the structural formula for tinzaparin sodium




Molecular formula:

C60H77N5S12O85Na16 to C122H159N10S23O169Na31


Relative Molecular Mass:

From 2,979 to 5,916 Da


Solubility: 

The solubility of tinzaparin sodium in water is >50 w/v%. Soluble in saline solutions. Practically insoluble in ethanol, acetone, benzene, chloroform, ether (Herr and Agerholm, 2011).


pH:

pH of 1% aqueous solution: 5.5-8.0 (Herr and Agerholm, 2011).


Optical rotation: > 35° (Herr and Agerholm, 2011).


References

I. European Medicines Agency (EMA), 2006. Committee for Medicinal Products for Human Use (CHMP). Guideline on the Environmental Risk Assessment of Medicinal Products for Human Use. EMEA/CHMP/SWP/4447/00 corr 2. 1 June 2006.

II. Herr SO, Agerholm C, 2011. LEO Pharma A/S. Tinzaparin sodium – Elucidation of Structure and other Characteristics.